Meeting people where they're at: A focus on pharmacist harm reduction roles in the opioid crisis

Bratberg, Jeffrey; Kubicsko, Danielle

doi:10.1002/jac5.1216

Cited by 4 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…19 In such cases, an emphasis on harm reduction is arguably even more important, because it may mitigate already exacerbated barriers to access for medications like naloxone or services like point-of-care testing. 20…”

Section: Harm Reduction In Community Pharmaciesmentioning

confidence: 99%

Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis

Agley

Meyerson

Eldridge

et al. 2022

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Section: Harm Reduction In Community Pharmaciesmentioning

confidence: 99%

Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis

Agley

Meyerson

Eldridge

et al. 2022

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

“…15 Pharmacists have demonstrated their role in addressing this crisis through various opioid stewardship activities, such as deprescribing, monitoring opioid use disorder, providing education and promoting harm-reduction strategies. 8,9,[16][17][18][19][20][21][22][23][24] With the exemptions, pharmacists are now better equipped to help address the opioid crisis by providing optimal care for patients who receive opioid medications. 25 To better understand the impact of the exemptions on pharmacists' ability to provide patient care, we set out to explore Canadian pharmacists' experiences with using the exemptions in practice.…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Pharmacists’ perceptions of the Canadian opioid regulatory exemptions on patient care and opioid stewardship

2021

View full text Add to dashboard Cite

Background: This study explored the perceptions of Canadian pharmacists about the barriers and facilitators of providing opioid stewardship activities in pharmacy practice, considering the subsection 56(1) class exemption under Health Canada’s Controlled Drugs and Substances Act (CDSA). Methods: Qualitative key informant telephone interviews were conducted with a convenience sample of pharmacists from across Canada. We included community or primary health care team-based pharmacists who self-identified as having experience with providing care for patients using opioids via the exemptions. All transcripts were de-identified, and thematic analysis was conducted to identify themes. Ethics approval was obtained. Results: Twenty pharmacists from community and primary health care teams, from all provinces and from urban and rural practices were interviewed. The following themes emerged: 1) optimization of opioid-related patient care, 2) jurisdictional impact and 3) awareness and education. Barriers and facilitators for opioid stewardship activities were identified. Discussion: The exemptions facilitated the pharmacists’ ability to provide opioid stewardship and positively affect patient care by providing continuity of and timely access to care. Our research demonstrated that pharmacists can responsibly and independently manage opioid prescriptions within this expanded scope, demonstrating the valuable contribution pharmacists can have in opioid stewardship. Conclusion: Pharmacists were willing and able to care for patients receiving opioid medication and thereby played a role in helping address the opioid crisis. The benefits of these exemptions were demonstrated beyond situations related to the COVID-19 pandemic and warrant consideration for consistent implementation across provincial and territorial jurisdictions, thereby ensuring equitable access to care for all Canadians.

show abstract

Assessing pharmacists’ knowledge, attitudes, and practices of opioid management within different patient populations

Martin,

Hughes,

Roller

et al. 2024

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Meeting people where they're at: A focus on pharmacist harm reduction roles in the opioid crisis

Cited by 4 publications

References 28 publications

Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis

Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis

Pharmacists’ perceptions of the Canadian opioid regulatory exemptions on patient care and opioid stewardship

Assessing pharmacists’ knowledge, attitudes, and practices of opioid management within different patient populations

Contact Info

Product

Resources

About